# HIRREM for Stage 1 Primary Hypertension

> **NCT03479697** · NA · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 5 (actual)

## Conditions studied

- Hypertension
- Blood Pressure
- Cardiovascular Diseases
- Cardiovascular Risk Factor
- Autonomic Nervous System Imbalance

## Interventions

- **DEVICE:** HIRREM
- **OTHER:** Continued Current Care

## Key facts

- **NCT ID:** NCT03479697
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-08
- **Primary completion:** 2020-11-13
- **Final completion:** 2020-11-13
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03479697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03479697, "HIRREM for Stage 1 Primary Hypertension". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03479697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*